Literature DB >> 4077737

Esperamicins, a novel class of potent antitumor antibiotics. I. Physico-chemical data and partial structure.

M Konishi, H Ohkuma, K Saitoh, H Kawaguchi, J Golik, G Dubay, G Groenewold, B Krishnan, T W Doyle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4077737     DOI： 10.7164/antibiotics.38.1605

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  15 in total

1.  Efficient and accurate characterization of the Bergman cyclization for several enediynes including an expanded substructure of esperamicin A1.

Authors:  Edward C Sherer; Karl N Kirschner; Frank C Pickard; Chantelle Rein; Steven Feldgus; George C Shields
Journal:  J Phys Chem B       Date:  2008-12-25       Impact factor: 2.991

2.  A macrophage-stimulating compound from a screen of microbial natural products.

Authors:  Julie A Perry; Kalinka Koteva; Chris P Verschoor; Wenliang Wang; Dawn M E Bowdish; Gerry D Wright
Journal:  J Antibiot (Tokyo)       Date:  2014-07-02       Impact factor: 2.649

Review 3.  A comprehensive review of glycosylated bacterial natural products.

Authors:  Sherif I Elshahawi; Khaled A Shaaban; Madan K Kharel; Jon S Thorson
Journal:  Chem Soc Rev       Date:  2015-11-07       Impact factor: 54.564

Review 4.  Heteroatom-Heteroatom Bond Formation in Natural Product Biosynthesis.

Authors:  Abraham J Waldman; Tai L Ng; Peng Wang; Emily P Balskus
Journal:  Chem Rev       Date:  2017-04-04       Impact factor: 60.622

Review 5.  Anticancer activity of natural and synthetic acetylenic lipids.

Authors:  Valery M Dembitsky
Journal:  Lipids       Date:  2006-10       Impact factor: 1.880

6.  Mode of action of C-1027, a new macromolecular antitumor antibiotic with highly potent cytotoxicity, on human hepatoma BEL-7402 cells.

Authors:  Y J Xu; D D Li; Y S Zhen
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

7.  Experimental antitumor activity of BMY-28175 a new fermentation derived antitumor agent.

Authors:  J E Schurig; W C Rose; H Kamei; Y Nishiyama; W T Bradner; D A Stringfellow
Journal:  Invest New Drugs       Date:  1990-02       Impact factor: 3.850

8.  Glycogenomics as a mass spectrometry-guided genome-mining method for microbial glycosylated molecules.

Authors:  Roland D Kersten; Nadine Ziemert; David J Gonzalez; Brendan M Duggan; Victor Nizet; Pieter C Dorrestein; Bradley S Moore
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-04       Impact factor: 11.205

9.  The effect of cerulenin on the production of esperamicin A1 by Actinomadura verrucosospora.

Authors:  K S Lam; D R Gustavson; J A Veitch; S Forenza
Journal:  J Ind Microbiol       Date:  1993-02

10.  Improved processes for the production and isolation of dynemicin A and large-scale fermentation in a 10,000-liter fermentor.

Authors:  K S Lam; J A Titus; T T Dabrah; D L Kimball; J M Veitch; D R Gustavson; B J Compton; J A Matson; S Forenza; J Ross
Journal:  J Ind Microbiol       Date:  1992-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.